Image For Activity Cover
The Science and Practice of Treating Patients with Opioid Use Disorder AK SUMMIT
Faculty

Presenter: Sarah Spencer, DO, ABAM; Candy Stockton, MD, FASAM; Annette Hubbard Case Manager/Peer 
Specialist

 

Course Overview

About: Overdose for people using opioids, stimulants and co-occurring use of stimulants and fentanyl are up 
more than 150 percent in Alaska in the last year, with Alaskan natives suffering triple rates of overdose deaths. 
New law changes have the potential to dramatically increase treatment access. This free training will provide 
on update on chronic opioid prescribing and tapering, discuss the basics of buprenorphine prescribing, utilizing 
buprenorphine in the hospital setting, discuss treating pregnant women with opioid use disorder (OUD), and 
look at integrating harm reduction into healthcare.

Learning Objectives: 
• Review evidence-based pain treatments and the potential role opioids can play.
• Explore strategies to reduce the potential harms of opioids.
• Review epidemiology, diagnosis, assessment, and standard for care to treat OUD.
• Review the pharmacology of buprenorphine.
• Identify and treat opioid withdrawal in hospitalized patients with opioid use disorder.
• Explain why ACOG, ASAM, and WHO all oppose detoxification for Opioid Use Disorder during
pregnancy.
• Name the 2 FDA approved treatments for OUD during pregnancy.
• Recognize why offering harm reduction services in healthcare settings is crucial


Summary
Availability: On-Demand
Cost: FREE
Credit Offered:
6 CME Credits
6 PA-CME Credits
6 Other Professionals Credits
6 Psychology (APA) Credits
6 Social Work (ACE) Credits
6 Nursing Credits
Recommended
 
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.



Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

 
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email PCSS-MOUD.

ORN
opioidresponsenetwork.org

Powered By